Literature DB >> 2951587

An adenovirus type 5 E1A protein with a single amino acid substitution blocks wild-type E1A transactivation.

G M Glenn, R P Ricciardi.   

Abstract

The E1A gene of adenovirus type 5 encodes a 289-amino-acid (289R) protein that transactivates early adenovirus promoters. We showed that the 289R protein of the E1A missense mutant gene hr5 is novel in that it inhibits the wild-type (wt) E1A protein from stimulating transcription from each of the early viral promoters E2, E3, and E4. Since both the hr5 and wt genes produced similar levels of E1A proteins, the ability of hr5 E1A to block transactivation was attributed to the replacement of serine by asparagine as position 185. We confirmed that this single amino acid substitution was responsible for blocking transactivation by showing equal inhibition with an hr5-wt hybrid E1A gene containing this missense mutation as the only alteration. The smaller 243R E1A protein of hr5 was not necessary for inhibition. Transcriptional activity from each early promoter was inhibited by at least 50% when the hr5 and wt E1A genes were present in equimolar amounts; complete inhibition occurred with a fivefold molar excess of the hr5 gene. Two other E1A missense mutant genes (hr3 and hr4) with amino acid substitutions in close proximity to that of hr5 failed to block wt E1A-induced transcription when similarly tested. Also, the hr5 E1A gene failed to impede the pseudorabies immediate early gene from transactivating the adenovirus E3 promoter, demonstrating that hr5 E1A inhibits wt E1A activation at the transcriptional, rather than the posttranscriptional, level. Although several possibilities were considered to account for this inhibition, the most likely is that the nonfunctional hr5 E1A protein competes with the wt 289R protein for a cellular transcription factor required for transactivation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951587      PMCID: PMC365170          DOI: 10.1128/mcb.7.3.1004-1011.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

2.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.

Authors:  M Sawadogo; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

6.  Preparative and analytical purification of DNA from agarose.

Authors:  B Vogelstein; D Gillespie
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Host-range mutants of adenovirus type 5 defective for growth in HeLa cells.

Authors:  T Harrison; F Graham; J Williams
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

8.  Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome.

Authors:  D J Spector; M McGrogan; H J Raskas
Journal:  J Mol Biol       Date:  1978-12-15       Impact factor: 5.469

9.  Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs.

Authors:  A J Berk; F Lee; T Harrison; J Williams; P A Sharp
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

10.  Structure of the adenovirus 2 early mRNAs.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

View more
  18 in total

1.  trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor.

Authors:  L C Webster; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

2.  Adenovirus E1A protein activates transcription of the E1A gene subsequent to transcription complex formation.

Authors:  J Schaack; J Logan; E Vakalopoulou; T Shenk
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4.

Authors:  S G Whalen; R C Marcellus; A Whalen; N G Ahn; R P Ricciardi; P E Branton
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

4.  Mutational analysis of autonomously functioning trans-activating peptides encoded by adenovirus E1A: evidence for two subdomains.

Authors:  R Pusztai; P M Loewenstein; M Green
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.

Authors:  L Pearson; J Garcia; F Wu; N Modesti; J Nelson; R Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  Identification of mouse adenovirus type 1 early region 1: DNA sequence and a conserved transactivating function.

Authors:  A O Ball; M E Williams; K R Spindler
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus.

Authors:  S D Gitlin; P F Lindholm; S J Marriott; J N Brady
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator.

Authors:  D M Becker; S M Hollenberg; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

9.  Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.

Authors:  H Bogerd; W C Greene
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter.

Authors:  J Garcia; F Wu; R Gaynor
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.